Iwata S - Search Results

1

Defective control of apoptosis, radiosensitivity, and spindle checkpoint in ataxia telangiectasia.

Takagi M, Delia D, Chessa L, Iwata S, Shigeta T, Kanke Y, Goi K, Asada M, Eguchi M, Kodama C, Mizutani S. Takagi M, et al. Among authors: iwata s. Cancer Res. 1998 Nov 1;58(21):4923-9. Cancer Res. 1998. PMID: 9810001

2

DNA damage-associated cell cycle and cell death control is differentially modulated by caffeine in clones with p53 mutations.

Takagi M, Shigeta T, Asada M, Iwata S, Nakazawa S, Kanke Y, Ishimoto K, Mizutani S. Takagi M, et al. Among authors: iwata s. Leukemia. 1999 Jan;13(1):70-7. doi: 10.1038/sj.leu.2401247. Leukemia. 1999. PMID: 10049063

3

Defective control of apoptosis and mitotic spindle checkpoint in heterozygous carriers of ATM mutations.

Shigeta T, Takagi M, Delia D, Chessa L, Iwata S, Kanke Y, Asada M, Eguchi M, Mizutani S. Shigeta T, et al. Among authors: iwata s. Cancer Res. 1999 Jun 1;59(11):2602-7. Cancer Res. 1999. PMID: 10363981

4

DNA damage-associated dysregulation of the cell cycle and apoptosis control in cells with germ-line p53 mutation.

Goi K, Takagi M, Iwata S, Delia D, Asada M, Donghi R, Tsunematsu Y, Nakazawa S, Yamamoto H, Yokota J, Tamura K, Saeki Y, Utsunomiya J, Takahashi T, Ueda R, Ishioka C, Eguchi M, Kamata N, Mizutani S. Goi K, et al. Among authors: iwata s. Cancer Res. 1997 May 15;57(10):1895-902. Cancer Res. 1997. PMID: 9157982

5

Anti-tumor activity of antizyme which targets the ornithine decarboxylase (ODC) required for cell growth and transformation.

Iwata S, Sato Y, Asada M, Takagi M, Tsujimoto A, Inaba T, Yamada T, Sakamoto S, Yata J, Shimogori T, Igarashi K, Mizutani S. Iwata S, et al. Oncogene. 1999 Jan 7;18(1):165-72. doi: 10.1038/sj.onc.1202275. Oncogene. 1999. PMID: 9926931

6

Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations.

Delia D, Goi K, Mizutani S, Yamada T, Aiello A, Fontanella E, Lamorte G, Iwata S, Ishioka C, Krajewski S, Reed JC, Pierotti MA. Delia D, et al. Among authors: iwata s. Oncogene. 1997 May 8;14(18):2137-47. doi: 10.1038/sj.onc.1201050. Oncogene. 1997. PMID: 9174049

7

p53 activity and chemotherapy.

Delia D, Mizutani S, Lamorte G, Goi K, Iwata S, Pierotti MA. Delia D, et al. Among authors: iwata s. Nat Med. 1996 Jul;2(7):724-5. doi: 10.1038/nm0796-724. Nat Med. 1996. PMID: 8673907 No abstract available.

8

Heterogeneity of the breakpoint in the ABL gene in cases with BCR/ABL transcript lacking ABL exon a2.

Iwata S, Mizutani S, Nakazawa S, Yata J. Iwata S, et al. Leukemia. 1994 Oct;8(10):1696-702. Leukemia. 1994. PMID: 7934165 Review.

9

Restoration of wild-type p16 down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human gliomas.

Harada H, Nakagawa K, Iwata S, Saito M, Kumon Y, Sakaki S, Sato K, Hamada K. Harada H, et al. Among authors: iwata s. Cancer Res. 1999 Aug 1;59(15):3783-9. Cancer Res. 1999. PMID: 10446996

10

Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrix.

Inamoto T, Yamochi T, Ohnuma K, Iwata S, Kina S, Inamoto S, Tachibana M, Katsuoka Y, Dang NH, Morimoto C. Inamoto T, et al. Among authors: iwata s. Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3470-7. doi: 10.1158/1078-0432.CCR-06-0361. Clin Cancer Res. 2006. PMID: 16740772

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,799 results

Search Page

Filters